Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling.

Berenjeno IM, Piñeiro R, Castillo SD, Pearce W, McGranahan N, Dewhurst SM, Meniel V, Birkbak NJ, Lau E, Sansregret L, Morelli D, Kanu N, Srinivas S, Graupera M, Parker VER, Montgomery KG, Moniz LS, Scudamore CL, Phillips WA, Semple RK, Clarke A, Swanton C, Vanhaesebroeck B.

Nat Commun. 2017 Nov 24;8(1):1773. doi: 10.1038/s41467-017-02002-4.

2.

Phosphoproteomic comparison of Pik3ca and Pten signalling identifies the nucleotidase NT5C as a novel AKT substrate.

Moniz LS, Surinova S, Ghazaly E, Velasco LG, Haider S, Rodríguez-Prados JC, Berenjeno IM, Chelala C, Vanhaesebroeck B.

Sci Rep. 2017 Jan 6;7:39985. doi: 10.1038/srep39985.

3.

Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.

Castillo SD, Tzouanacou E, Zaw-Thin M, Berenjeno IM, Parker VE, Chivite I, Milà-Guasch M, Pearce W, Solomon I, Angulo-Urarte A, Figueiredo AM, Dewhurst RE, Knox RG, Clark GR, Scudamore CL, Badar A, Kalber TL, Foster J, Stuckey DJ, David AL, Phillips WA, Lythgoe MF, Wilson V, Semple RK, Sebire NJ, Kinsler VA, Graupera M, Vanhaesebroeck B.

Sci Transl Med. 2016 Mar 30;8(332):332ra43. doi: 10.1126/scitranslmed.aad9982.

4.

The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.

Aksoy E, Taboubi S, Torres D, Delbauve S, Hachani A, Whitehead MA, Pearce WP, Berenjeno IM, Nock G, Filloux A, Beyaert R, Flamand V, Vanhaesebroeck B.

Nat Immunol. 2012 Nov;13(11):1045-1054. doi: 10.1038/ni.2426. Epub 2012 Sep 30. Erratum in: Nat Immunol. 2013 Aug;14(8):877. Berenjeno-Martin, Inma [corrected to Berenjeno, Inma M].

5.

Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor.

Berenjeno IM, Guillermet-Guibert J, Pearce W, Gray A, Fleming S, Vanhaesebroeck B.

Biochem J. 2012 Feb 15;442(1):151-9. doi: 10.1042/BJ20111741.

6.

Activity of any class IA PI3K isoform can sustain cell proliferation and survival.

Foukas LC, Berenjeno IM, Gray A, Khwaja A, Vanhaesebroeck B.

Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11381-6. doi: 10.1073/pnas.0906461107. Epub 2010 Jun 7.

7.

A transcriptional cross-talk between RhoA and c-Myc inhibits the RhoA/Rock-dependent cytoskeleton.

Sauzeau V, Berenjeno IM, Citterio C, Bustelo XR.

Oncogene. 2010 Jul 1;29(26):3781-92. doi: 10.1038/onc.2010.134. Epub 2010 May 10.

8.

PI3K regulatory subunits lose control in cancer.

Berenjeno IM, Vanhaesebroeck B.

Cancer Cell. 2009 Dec 8;16(6):449-50. doi: 10.1016/j.ccr.2009.11.017. Erratum in: Cancer Cell. 2010 Feb 17;17(2):213. Martin-Berenjeno, Inma [corrected to Berenjeno, Inma Martin].

9.

Identification of the Rock-dependent transcriptome in rodent fibroblasts.

Berenjeno IM, Bustelo XR.

Clin Transl Oncol. 2008 Nov;10(11):726-38.

10.

Transcriptomal profiling of site-specific Ras signals.

Agudo-Ibáñez L, Núñez F, Calvo F, Berenjeno IM, Bustelo XR, Crespo P.

Cell Signal. 2007 Nov;19(11):2264-76. Epub 2007 Jul 4.

11.

GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo.

Bustelo XR, Sauzeau V, Berenjeno IM.

Bioessays. 2007 Apr;29(4):356-70. Review.

12.

Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases.

Berenjeno IM, Núñez F, Bustelo XR.

Oncogene. 2007 Jun 21;26(29):4295-305. Epub 2007 Jan 8.

13.

Involvement of the Rho/Rac family member RhoG in caveolar endocytosis.

Prieto-Sánchez RM, Berenjeno IM, Bustelo XR.

Oncogene. 2006 May 18;25(21):2961-73.

Supplemental Content

Loading ...
Support Center